Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 28 Neoplasms 27 Prostatic Neoplasms 22 Colorectal Neoplasms 16 Head and Neck Neoplasms 13 Pancreatic Neoplasms 12 Brain Neoplasms 11 Melanoma 10 Neoplasm Metastasis 9 Lung Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Carcinoma, Renal Cell 8 Carcinoma, Non-Small-Cell Lung 8 Triple Negative Breast Neoplasms 7 Recurrence 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma, Follicular 7 Leukemia, Myeloid, Acute 7 Glioblastoma 7 Multiple Myeloma 6 Lymphoma 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Ovarian Neoplasms 5 Leukemia 5 Hematologic Neoplasms 5 Sarcoma 4 Lymphoma, B-Cell 4 Liver Neoplasms 4 Kidney Neoplasms 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Communication Disorders × 1 year × Clear all

NCT04969874 2026-05-12

E-CRIL_MAX

University Hospital, Toulouse

Phase NA Withdrawn

Communication Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡